Accordingly, it would be reasonable to use antioxidants in AD therapy14,17, and the development of cholinesterase inhibitors with additional antioxidant properties is a present-day trend in the search for new effective treatments for AD18–20. Here, BCHE is linked to Alzheimer disease.